Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Axogen, Inc.
Report date August 14, 2019 · Filed August 23, 2019
Section 16 reporting ended · disclosed 2019-08-23. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 20, 2018 Filed Sep 24, 2018 20:43 UTC | Axogen, Inc. AXGN · Entity 4297 | Exercise / conversionDirector Stock Option (right to purchase) · Derivative | 12,000 | $0.00 Strike: $2.75 | $0.00 |
DisclosureSEC source: 0001179110-18-011633 · edgar.xml · derivative · entry 4 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2018-10-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2018 Filed Sep 24, 2018 20:43 UTC | Axogen, Inc. AXGN · Entity 4297 | Exercise / conversionDirector Stock Option (right to purchase) · Derivative | 494 | $0.00 Strike: $0.27 | $0.00 |
DisclosureSEC source: 0001179110-18-011633 · edgar.xml · derivative · entry 3 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 494 shares Expires 2018-11-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2018 Filed Sep 24, 2018 20:43 UTC | Axogen, Inc. AXGN · Entity 4297 | Exercise / conversionCommon Stock | 12,000 | $2.75 | $33,000.00 |
DisclosureSEC source: 0001179110-18-011633 · edgar.xml · nonDerivative · entry 2 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,693 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares of common stock include 372 shares held by the Jamie Grooms Trust, of which Mr. Grooms is the trustee. Read SEC document |
| September 20, 2018 Filed Sep 24, 2018 20:43 UTC | Axogen, Inc. AXGN · Entity 4297 | Exercise / conversionCommon Stock | 494 | $0.27 | $133.38 |
DisclosureSEC source: 0001179110-18-011633 · edgar.xml · nonDerivative · entry 1 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,693 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares of common stock include 372 shares held by the Jamie Grooms Trust, of which Mr. Grooms is the trustee. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:11 UTC | Axogen, Inc. AXGN · Entity 4297 | GrantStock Option (right to purchase) · Derivative | 4,780 | $0.00 Strike: $49.65 | $0.00 |
DisclosureSEC source: 0001179110-18-008111 · edgar.xml · derivative · entry 1 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,780 Underlying: Common Stock · 4,780 shares Expires 2028-06-01 F1 · derivative.exercise_date: Non-qualified stock option grant for service as Director on Company's Board of directors. Options vest in equal installments every three months for the first nine months, with the final installment vesting on the earlier of the date of the 2019 annual shareholders meeting or May 31, 2019. Number of shares pursuant to option are based on $120,000 valuation as of the grant date. Read SEC document |
| February 21, 2018 Filed Feb 24, 2018 00:08 UTC | Axogen, Inc. AXGN · Entity 4297 | SaleCommon Stock | 57,406 | $28.40 | $1,630,330.40 |
DisclosureSEC source: 0001104659-18-011770 · a4.xml · nonDerivative · entry 1 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 372 F3 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017. F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.80 to $28.50. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Trust, of which Mr. Grooms is a trustee. Read SEC document |
| February 20, 2018 Filed Feb 21, 2018 00:52 UTC | Axogen, Inc. AXGN · Entity 4297 | SaleCommon Stock | 36,740 | $27.90 | $1,025,046.00 |
DisclosureSEC source: 0001104659-18-010876 · a4.xml · nonDerivative · entry 2 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 62,861 F4 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.10 to $28.20. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.nature: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Trust, of which Mr. Grooms is a trustee. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 00:52 UTC | Axogen, Inc. AXGN · Entity 4297 | SaleCommon Stock | 26,655 | $27.35 | $729,014.25 |
DisclosureSEC source: 0001104659-18-010876 · a4.xml · nonDerivative · entry 1 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 99,601 F4 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017. F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.10 to $27.65. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.nature: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Trust, of which Mr. Grooms is a trustee. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 00:56 UTC | Axogen, Inc. AXGN · Entity 4297 | SaleCommon Stock | 43,403 | $27.11 | $1,176,655.33 |
DisclosureSEC source: 0001104659-18-010127 · a4.xml · nonDerivative · entry 5 Grooms Jamie Mark · CIK 0001530935 · Director · VP, CFO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 126,256 F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.50 to $27.375. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.nature: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Trust, of which Mr. Grooms is a trustee. Read SEC document |
| February 15, 2018 Filed Feb 17, 2018 01:14 UTC Amendment | Axogen, Inc. AXGN · Entity 4297 | SaleCommon Stock | 43,403 | $27.11 | $1,176,655.33 |
DisclosureSEC source: 0001104659-18-010448 · a4a.xml · nonDerivative · entry 5 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 126,256 F8 · kind: The transactions reported on the original Form 4 filed on February 15, 2018 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017. F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.50 to $27.375. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.nature: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Trust, of which Mr. Grooms is a trustee. Read SEC document |
| February 14, 2018 Filed Feb 16, 2018 00:56 UTC | Axogen, Inc. AXGN · Entity 4297 | SaleCommon Stock | 9,073 | $26.71 | $242,339.83 |
DisclosureSEC source: 0001104659-18-010127 · a4.xml · nonDerivative · entry 4 Grooms Jamie Mark · CIK 0001530935 · Director · VP, CFO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.20 to $26.95. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F4 · ownership.nature: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Children's Trust, of which Mr. Grooms is a trustee. Read SEC document |
| February 14, 2018 Filed Feb 16, 2018 00:56 UTC | Axogen, Inc. AXGN · Entity 4297 | SaleCommon Stock | 32,936 | $26.72 | $880,049.92 |
DisclosureSEC source: 0001104659-18-010127 · a4.xml · nonDerivative · entry 3 Grooms Jamie Mark · CIK 0001530935 · Director · VP, CFO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 169,659 F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.10 to $27.05. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.nature: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Trust, of which Mr. Grooms is a trustee. Read SEC document |
| February 14, 2018 Filed Feb 17, 2018 01:14 UTC Amendment | Axogen, Inc. AXGN · Entity 4297 | SaleCommon Stock | 9,073 | $26.71 | $242,339.83 |
DisclosureSEC source: 0001104659-18-010448 · a4a.xml · nonDerivative · entry 4 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F8 · kind: The transactions reported on the original Form 4 filed on February 15, 2018 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.20 to $26.95. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F4 · ownership.nature: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Children's Trust, of which Mr. Grooms is a trustee. Read SEC document |
| February 14, 2018 Filed Feb 17, 2018 01:14 UTC Amendment | Axogen, Inc. AXGN · Entity 4297 | SaleCommon Stock | 32,936 | $26.72 | $880,049.92 |
DisclosureSEC source: 0001104659-18-010448 · a4a.xml · nonDerivative · entry 3 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 169,659 F8 · kind: The transactions reported on the original Form 4 filed on February 15, 2018 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.10 to $27.05. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.nature: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Trust, of which Mr. Grooms is a trustee. Read SEC document |
| February 13, 2018 Filed Feb 16, 2018 00:56 UTC | Axogen, Inc. AXGN · Entity 4297 | SaleCommon Stock | 3,200 | $26.22 | $83,904.00 |
DisclosureSEC source: 0001104659-18-010127 · a4.xml · nonDerivative · entry 2 Grooms Jamie Mark · CIK 0001530935 · Director · VP, CFO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 9,073 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.60. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F4 · ownership.nature: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Children's Trust, of which Mr. Grooms is a trustee. Read SEC document |
| February 13, 2018 Filed Feb 16, 2018 00:56 UTC | Axogen, Inc. AXGN · Entity 4297 | SaleCommon Stock | 7,100 | $26.20 | $186,020.00 |
DisclosureSEC source: 0001104659-18-010127 · a4.xml · nonDerivative · entry 1 Grooms Jamie Mark · CIK 0001530935 · Director · VP, CFO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 202,595 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.55. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.nature: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Trust, of which Mr. Grooms is a trustee. Read SEC document |
| February 13, 2018 Filed Feb 17, 2018 01:14 UTC Amendment | Axogen, Inc. AXGN · Entity 4297 | SaleCommon Stock | 3,200 | $26.22 | $83,904.00 |
DisclosureSEC source: 0001104659-18-010448 · a4a.xml · nonDerivative · entry 2 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 9,073 F8 · kind: The transactions reported on the original Form 4 filed on February 15, 2018 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.60. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F4 · ownership.nature: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Children's Trust, of which Mr. Grooms is a trustee. Read SEC document |
| February 13, 2018 Filed Feb 17, 2018 01:14 UTC Amendment | Axogen, Inc. AXGN · Entity 4297 | SaleCommon Stock | 7,100 | $26.20 | $186,020.00 |
DisclosureSEC source: 0001104659-18-010448 · a4a.xml · nonDerivative · entry 1 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 202,595 F8 · kind: The transactions reported on the original Form 4 filed on February 15, 2018 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017. F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.55. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.nature: These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Trust, of which Mr. Grooms is a trustee. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 00:45 UTC | Axogen, Inc. AXGN · Entity 4297 | SaleCommon Stock | 16,585 | $26.34 | $436,848.90 |
DisclosureSEC source: 0001179110-17-015344 · edgar.xml · nonDerivative · entry 2 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,607 F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.10 to $26.90. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F5 · balance_after: These shares of common stock include 107,883 shares held by the Jamie Grooms Trust, of which Mr. Grooms is the trustee. Read SEC document |
| December 11, 2017 Filed Dec 14, 2017 00:45 UTC | Axogen, Inc. AXGN · Entity 4297 | SaleCommon Stock | 21,820 | $26.35 | $574,957.00 |
DisclosureSEC source: 0001179110-17-015344 · edgar.xml · nonDerivative · entry 1 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,192 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017 (the "Plan"). All shares pursuant to the Plan have been sold as of the last sales reported herein. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.05 to $26.65. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: These shares of common stock include 108,883 shares held by the Jamie Grooms Trust, of which Mr. Grooms is the trustee. Read SEC document |
| December 08, 2017 Filed Dec 8, 2017 23:30 UTC | Axogen, Inc. AXGN · Entity 4297 | SaleCommon Stock | 31,805 | $26.37 | $838,697.85 |
DisclosureSEC source: 0001179110-17-015168 · edgar.xml · nonDerivative · entry 3 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,312 F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.15 to $26.70. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F5 · balance_after: These shares of common stock include 108,883 shares held by the Jamie Grooms Trust, of which Mr. Grooms is the trustee. Read SEC document |
| December 08, 2017 Filed Dec 14, 2017 00:44 UTC Amendment | Axogen, Inc. AXGN · Entity 4297 | SaleCommon Stock | 31,805 | $26.37 | $838,697.85 |
DisclosureSEC source: 0001179110-17-015343 · edgar.xml · nonDerivative · entry 3 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,012 F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.15 to $26.70. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F5 · balance_after: These shares of common stock include 108,883 shares held by the Jamie Grooms Trust, of which Mr. Grooms is the trustee. F7 · balance_after: Amended as a result of 2,300 shares sold on December 7, 2017 inadvertently not being disclosed. Such December 7, 2017 transaction has been revised resulting in a change in the aggregate number of shares sold and the weighted average sale price for such day, along with change in holdings after the December 7 and 8, 2017 transactions. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 23:30 UTC | Axogen, Inc. AXGN · Entity 4297 | SaleCommon Stock | 31,200 | $26.50 | $826,800.00 |
DisclosureSEC source: 0001179110-17-015168 · edgar.xml · nonDerivative · entry 2 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,117 F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.95. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F2 · balance_after: These shares of common stock include 132,883 shares held by the Jamie Grooms Trust, of which Mr. Grooms is the trustee. Read SEC document |
| December 07, 2017 Filed Dec 14, 2017 00:44 UTC Amendment | Axogen, Inc. AXGN · Entity 4297 | SaleCommon Stock | 33,500 | $26.47 | $886,745.00 |
DisclosureSEC source: 0001179110-17-015343 · edgar.xml · nonDerivative · entry 2 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,817 F7 · shares: Amended as a result of 2,300 shares sold on December 7, 2017 inadvertently not being disclosed. Such December 7, 2017 transaction has been revised resulting in a change in the aggregate number of shares sold and the weighted average sale price for such day, along with change in holdings after the December 7 and 8, 2017 transactions. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.95. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F7 · price: Amended as a result of 2,300 shares sold on December 7, 2017 inadvertently not being disclosed. Such December 7, 2017 transaction has been revised resulting in a change in the aggregate number of shares sold and the weighted average sale price for such day, along with change in holdings after the December 7 and 8, 2017 transactions. F2 · balance_after: These shares of common stock include 132,883 shares held by the Jamie Grooms Trust, of which Mr. Grooms is the trustee. F7 · balance_after: Amended as a result of 2,300 shares sold on December 7, 2017 inadvertently not being disclosed. Such December 7, 2017 transaction has been revised resulting in a change in the aggregate number of shares sold and the weighted average sale price for such day, along with change in holdings after the December 7 and 8, 2017 transactions. Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 23:30 UTC | Axogen, Inc. AXGN · Entity 4297 | SaleCommon Stock | 21,290 | $26.22 | $558,223.80 |
DisclosureSEC source: 0001179110-17-015168 · edgar.xml · nonDerivative · entry 1 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,317 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $27.00. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F2 · balance_after: These shares of common stock include 132,883 shares held by the Jamie Grooms Trust, of which Mr. Grooms is the trustee. Read SEC document |
| December 06, 2017 Filed Dec 14, 2017 00:44 UTC Amendment | Axogen, Inc. AXGN · Entity 4297 | SaleCommon Stock | 21,290 | $26.22 | $558,223.80 |
DisclosureSEC source: 0001179110-17-015343 · edgar.xml · nonDerivative · entry 1 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,317 F6 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017. F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $27.00. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F2 · balance_after: These shares of common stock include 132,883 shares held by the Jamie Grooms Trust, of which Mr. Grooms is the trustee. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 20:56 UTC | Axogen, Inc. AXGN · Entity 4297 | Exercise / conversionDirector Stock Option (right to purchase) · Derivative | 3,197 | $0.00 Strike: $0.27 | $0.00 |
DisclosureSEC source: 0001179110-17-013746 · edgar.xml · derivative · entry 4 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,197 shares Expires 2017-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 20:56 UTC | Axogen, Inc. AXGN · Entity 4297 | Exercise / conversionDirector Stock Option (right to purchase) · Derivative | 11,182 | $0.00 Strike: $0.27 | $0.00 |
DisclosureSEC source: 0001179110-17-013746 · edgar.xml · derivative · entry 3 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,182 shares Expires 2017-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 20:56 UTC | Axogen, Inc. AXGN · Entity 4297 | Tax withholdingCommon Stock | 189 | $20.60 | $3,893.40 |
DisclosureSEC source: 0001179110-17-013746 · edgar.xml · nonDerivative · entry 2 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 365,607 F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 14,397 shares by means of a cashless exercise. A cashless exercise is a method of exercising a stock option in which the option holder pays the exercise price using shares the reporting person would have received pursuant to the option exercise. As a result of this cashless exercise, the Reporting Person, on a net basis, acquired ownership of an additional 14,190 shares of common stock. F2 · balance_after: These shares of common stock include 132,883 shares held by the Jamie Grooms Trust, of which Mr. Grooms is the trustee. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 20:56 UTC | Axogen, Inc. AXGN · Entity 4297 | Exercise / conversionCommon Stock | 14,379 | $0.27 | $3,882.33 |
DisclosureSEC source: 0001179110-17-013746 · edgar.xml · nonDerivative · entry 1 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 365,796 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 14,397 shares by means of a cashless exercise. A cashless exercise is a method of exercising a stock option in which the option holder pays the exercise price using shares the reporting person would have received pursuant to the option exercise. As a result of this cashless exercise, the Reporting Person, on a net basis, acquired ownership of an additional 14,190 shares of common stock. F2 · balance_after: These shares of common stock include 132,883 shares held by the Jamie Grooms Trust, of which Mr. Grooms is the trustee. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 20:48 UTC | Axogen, Inc. AXGN · Entity 4297 | GrantStock Option (right to purchase) · Derivative | 15,000 | $0.00 Strike: $14.85 | $0.00 |
DisclosureSEC source: 0001179110-17-008548 · edgar.xml · derivative · entry 1 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-06-01 F1 · derivative.exercise_date: Non-qualified stock option grant for service as Director on Company's Board of directors. Options vest in equal installments every three months for the first nine months, with the final installment vesting on the date of the then current annual meeting. Read SEC document |
| December 29, 2016 Filed Jan 3, 2017 21:46 UTC | Axogen, Inc. AXGN · Entity 4297 | GrantStock Option (right to purchase) · Derivative | 5,000 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0001179110-17-000085 · edgar.xml · derivative · entry 1 Grooms Jamie Mark · CIK 0001530935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2026-12-29 F1 · derivative.exercise_date: Non-qualified stock option grant for service as Director on Company's Board of directors. Vesting is 100% upon the director's re-election to the Company's Board of Directors at the 2017 Annual Meeting of Shareholders. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.